D. E. Shaw & Co., Inc.
- SEC CIK
- 0001009207
- Latest filing
- Aug 14, 2026
CYTK holding history
Cytokinetics Inc in every 13F filed by D. E. Shaw & Co., Inc., including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.
CYTK overviewAll 13F holders of CYTKFull Q2 2026 holdings
- Shares (Q2 2026)
- 1,048,103
- Value
- $89.3M
- % of portfolio
- 0.1%
- Quarters held
- 11
- Since Q1 2021
| Quarter | Shares | Value | % of portfolio | Share change | Action | All holders |
|---|---|---|---|---|---|---|
| Q2 2026 | 1,048,103 | $89.3M | 0.1% | +341,472+48.3% | Added | Holders |
| Q1 2026 | 706,631 | $46.6M | <0.1% | +587,410+492.7% | Added | Holders |
| Q4 2025 | 119,221 | $7.58M | <0.1% | +105,618+776.4% | Added | Holders |
| Q3 2025 | 13,603 | $747.6K | <0.1% | −5,481−28.7% | Reduced | Holders |
| Q2 2025 | 19,084 | $630.5K | <0.1% | +5,782+43.5% | Added | Holders |
| Q1 2025 | 13,302 | $534.6K | <0.1% | +13,302 | New | Holders |
| Q4 2024 | 0 | $0 | 0.0% | −11,790−100.0% | Sold out | Holders |
| Q3 2024 | 11,790 | $622.5K | <0.1% | +11,790 | New | Holders |
| Q2 2024 | 0 | $0 | 0.0% | −36,554−100.0% | Sold out | Holders |
| Q1 2024 | 36,554 | $2.56M | <0.1% | +36,554 | New | Holders |
| Q4 2022 | 0 | $0 | 0.0% | −41,935−100.0% | Sold out | Holders |
| Q3 2022 | 41,935 | $2.03M | <0.1% | +41,935 | New | Holders |
| Q1 2022 | 0 | $0 | 0.0% | −106,281−100.0% | Sold out | Holders |
| Q4 2021 | 106,281 | $4.84M | <0.1% | +106,281 | New | Holders |
| Q2 2021 | 0 | $0 | 0.0% | −92,247−100.0% | Sold out | Holders |
| Q1 2021 | 92,247 | $2.15M | <0.1% | – | – | Holders |
Livermore's 13F data starts with Q1 2021, so Q1 2021 has no change from the previous quarter.